PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16757730-7	2006	Candesartan treatment from the onset of obstruction attenuated the reduction in GFR (3.1 +/- 0.4 vs. 1.7 +/- 0.3 ml.min(-1).kg(-1)) and partially prevented the reduction in the expression of AQP2 (66 +/- 21 vs. 13 +/- 2%, n = 7; P < 0.05), NaPi-2 (84 +/- 6 vs. 57 +/- 10%, n = 7; P < 0.05), and NKCC2 (89 +/- 12 vs. 46% +/- 11, n = 7; P < 0.05).	candesartan	0-11	aquaporin 2	Rattus norvegicus	191-195	
16757730-10	2006	In conclusion, candesartan prevents dysregulation of AQP2, sodium transporters, and development of polyuria seen in BUO.	candesartan	15-26	aquaporin 2	Rattus norvegicus	53-57